Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer

This publication has 15 references indexed in Scilit:

• Intraarterial Adjuvant Chemotherapy after Pancreaticoduodenectomy for Pancreatic Cancer: Significant Reduction in Occurrence of Liver Metastasis
  World Journal of Surgery, 1999
• Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional review
  Langenbecks Archives Of Surgery, 1999
• In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols
  Seminars in Surgical Oncology, 1998
• The role of gemcitabine in the treatment of other tumours
  British Journal of Cancer, 1998
• A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors
  Investigational New Drugs, 1997
• Clinical Response Benefit in Patients with Advanced Pancreatic Cancer
  Digestion, 1997
• Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine
  Investigational New Drugs, 1996
• Preclinical characteristics of gemcitabine
  Anti-Cancer Drugs, 1995
• Activity of 2, 2 -difluorodeoxycytidine (Gemcitabine) against human tumor colony forming units
  Anti-Cancer Drugs, 1992
• Primary Bioassay of Human Tumor Stem Cells
  Science, 1977